Mixed cryoglobulinaemic vasculitis (MCV) is an immune-complex-mediated systemic vasculitis characterised by heterogeneous clinical manifestations mainly involving lymphatic system, skin, kidney and peripheral nervous system. Although MCV patients have been included in priority programs for vaccination against SARS-CoV-2 in Italy, limited information is available for these patients. Aims of this multicentre Italian study were to investigate SARS-CoV-2 vaccination rate in MCV patients and its safety profile.

COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis / Vacchi, Caterina; Testoni, Sofia; Visentini, Marcella; Zani, Roberta; Lauletta, Gianfranco; Gragnani, Laura; Filippini, Davide; Mazzaro, Cesare; Fraticelli, Paolo; Quartuccio, Luca; Padoan, Roberto; Castelnovo, Laura; Zignego, Anna Linda; Ferri, Clodoveo; Scarpato, Salvatore; Casato, Milvia; Hoxha, Ariela; Salvarani, Carlo; Monti, Giuseppe; Galli, Massimo; Sebastiani, Marco. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 41:4(2023), pp. 787-791. [10.55563/clinexprheumatol/ldv88a]

COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis

Vacchi, Caterina;Testoni, Sofia;Ferri, Clodoveo;Salvarani, Carlo;Sebastiani, Marco
2023

Abstract

Mixed cryoglobulinaemic vasculitis (MCV) is an immune-complex-mediated systemic vasculitis characterised by heterogeneous clinical manifestations mainly involving lymphatic system, skin, kidney and peripheral nervous system. Although MCV patients have been included in priority programs for vaccination against SARS-CoV-2 in Italy, limited information is available for these patients. Aims of this multicentre Italian study were to investigate SARS-CoV-2 vaccination rate in MCV patients and its safety profile.
2023
41
4
787
791
WOS:001007133700007
2-s2.0-85141715740
35894064
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis / Vacchi, Caterina; Testoni, Sofia; Visentini, Marcella; Zani, Roberta; Lauletta, Gianfranco; Gragnani, Laura; Filippini, Davide; Mazzaro, Cesare; Fraticelli, Paolo; Quartuccio, Luca; Padoan, Roberto; Castelnovo, Laura; Zignego, Anna Linda; Ferri, Clodoveo; Scarpato, Salvatore; Casato, Milvia; Hoxha, Ariela; Salvarani, Carlo; Monti, Giuseppe; Galli, Massimo; Sebastiani, Marco. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 41:4(2023), pp. 787-791. [10.55563/clinexprheumatol/ldv88a]
Vacchi, Caterina; Testoni, Sofia; Visentini, Marcella; Zani, Roberta; Lauletta, Gianfranco; Gragnani, Laura; Filippini, Davide; Mazzaro, Cesare; Fraticelli, Paolo; Quartuccio, Luca; Padoan, Roberto; Castelnovo, Laura; Zignego, Anna Linda; Ferri, Clodoveo; Scarpato, Salvatore; Casato, Milvia; Hoxha, Ariela; Salvarani, Carlo; Monti, Giuseppe; Galli, Massimo; Sebastiani, Marco
File in questo prodotto:
File Dimensione Formato  
article-6.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 252.01 kB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
252.01 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1284444
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact